The Future of 
Vascular Bio-Technology


Jim DeMesa, MD, MBA:
Chief Executive Officer

Dr. DeMesa has been a practicing physician and has served as a senior executive with several international pharmaceutical and biotech companies, both public and private, in the areas of corporate management, regulatory affairs, and pre-clinical and clinical pharmaceutical and medical device product development. In addition to his role at Integene, Dr. DeMesa is currently on the Board of Directors of Induce Biologics, a regenerative medicine company and OncoSec Medical, a cancer company. In 2008, Dr. DeMesa retired from his role as President, Chief Executive Officer and a director of Migenix Inc., a public biotechnology company focused on infectious and neurodegenerative diseases. From 1997 to 2001, he was President, Chief Executive Officer and a director of GenSci Regeneration Sciences Inc., a public biotech company involved in regenerative medicine (now part of Integra LifeSciences, NASD: IART). During his tenure at these two companies, Dr. DeMesa led the acquisition of several technologies and companies and completed multiple strategic partnership transactions with companies such as J&J, Astellas Pharmaceuticals, United Therapeutics, and Cadence Pharmaceuticals. He also led multiple successful financings totaling over $150 million. From 1992 to 1997, he was Vice President, Medical and Regulatory Affairs at Biodynamics International, Inc. (now part of RTI Surgical, NASD: RTIX), and from 1989 to 1992 was Vice President, Medical and Regulatory Affairs at Bentley Pharmaceuticals (now part of Teva Pharmaceuticals, NYSE: TEVA). Dr. DeMesa is a co-founder of CommGeniX, a medical communications company, and MedXcel, a medical education company. Dr. DeMesa attended the University of South Florida where he received his B.A. (Chemistry), M.D. and M.B.A. degrees and did his medical residency at the University of North Carolina. He is the author of two books and speaks regularly to companies and organizations throughout North America.

Keith Webster, BA PhD FAHA:
Founder and Chief Scientific Officer

Dr. Webster is currently the Director of the Vascular Biology Institute at the University of Miami Florida.  He also holds the Walter G. Ross Distinguished Chair of Vascular Biology at the University  Miami Miller School of Medicine.  Dr. Webster is also a Professor in the Department of Molecular and Cellular Pharmacology. 

Nancy Coulson, MBA:
Vice President, Regulatory Affairs
Mrs. Coulson has spent three decades in the regulatory arena working on multiple device, biologic, and tissue-based products with Johnson & Johnson, GenSci Regeneration Sciences, Bristol-Myers Squibb, Baush  & Lomb, and Migenix.

David Greenspan, PhD
Vice President, Product Development

Dr. Greenspan is an experienced product development and quality systems expert, with over 32 years of experience in the medical device industry.  He has been responsible for taking several products from concept to market and has extensive experience in the areas of design control, regulatory processes, and project management.

Clinical Advisory Board Members

Murray Shames, M.D.

Professor of Surgery and Radiology and Program Director Vascular Surgery, Division of Vascular and Endovascular Surgery USF Health Morsani School of Medicine.

Dr. Paul A. Kurlansky
A specialist in Cardiothoracic Surgery and General Surgery, Director of Research, Florida Heart Institute.

Board Members:

Michael Gold,  Executive Chairman
Mr. Gold has a long career in corporate development in the US. He is currently Chairman and co-founder of Events International Network LLC  a  media,  marketing, and advertising company with offices in Miami and New York and London.

Dr. Marvin Sackner MD.
Dr. Sackner was the former Chief of Medicine Mount Sinai Hospital Miami Beach Florida . He was the CEO of Non Invasive Monitoring Systems, Miami Florida, and Vice Chairman of the board of Continucare Corporation Miami Florida.

Dr. Eduardo De Marchenna MD
Dr. De Marchenna is a cardiologist, former chief of Medicine and Cardiology University of Miami Florida, and the Director of the University of Miami International Center of Medical Research.


Website Builder